NDATOPICALCREAM
Approved
Dec 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
2/8 — Basic
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EMLA is a topical cream combining lidocaine and prilocaine, two local anesthetics that work synergistically to provide rapid numbing at the site of application. It is indicated for topical anesthesia prior to minor surgical procedures, dermatological treatments, and venipuncture. The combination penetrates the stratum corneum and blocks sodium channels in nerve fibers, producing local anesthesia without systemic absorption at therapeutic doses.
LOE Approaching
As LOE approaches, the brand team is likely consolidating operations and transitioning focus to generic defense or managed care retention strategies, suggesting smaller team size and defensive commercial positioning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
Started Sep 2024
164 enrolled
Tourette Syndrome
A Study to Assess Therapeutic Equivalence Between Test EMLA Patch With Marketed EMLA Patch in Healthy Subjects.
Started Oct 2017
32 enrolled
Pain
Jet Injection of 1% Buffered Lidocaine Versus Topical EMLA for Local Anesthesia Before Lumbar Puncture in Children
Started Sep 2012
66 enrolled
Lumbar PunctureTopical Analgesia
Career Relevance
Working on EMLA offers limited career growth in a declining product category, with roles focused on defensive strategies, generic competition management, and channel maintenance rather than innovation or launch excitement. This assignment is best viewed as a stabilization role or stepping stone to a higher-priority portfolio asset.
Worked on EMLA at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.